GlaxoSmithKline Intellectual Property Development Limited
发明人:
SANG, Yingxia,WAN, Zehong,ZHANG, Qing
申请号：
ES14701355
公开号：
ES2642762T3
申请日:
2014.01.23
申请国别(地区):
ES
年份:
2017
代理人:
摘要：
The present invention relates to novel compounds that inhibit Lp-PLA2 activity, processes for their preparation, to compositions containing them and to their use in the treatment of diseases associated with the activity of Lp-PLA2, for example atherosclerosis, Alzheimer's disease.
